Successful treatment with hemodiafiltration for a chronic renal failure patient with hyperchloremic metabolic acidosis associated with hepatic coma

Takahiro Masuda(Jichi Medical University), Eiji Kusano(Edogawa Hospital), Takashi Otomo(Jichi Medical University), Kentaro Sugano(Jichi Medical University), Morimasa Amemiya(Jichi Medical University), Genta Nagae(Jichi Medical University), Yoshiyuki Morishita(Jichi Medical University), Norio Isoda(Jichi Medical University), Yasushi Asano(Koga Hospital), Shigeaki Muto(Jichi Medical University), Hidekazu Tsuruoka, Kenichi Ido(Jichi Medical University), Hideaki Inamori(Jichi Medical University)
Nihon Toseki Igakkai Zasshi
January 1, 2004
10.4009/jsdt.37.1809
Cited by 1

Related Papers

Kyoto global consensus report on<i>Helicobacter pylori</i>gastritis
|Gut|2015|1.8k
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|720
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
|American Journal of Physiology-Renal Physiology|2013|481
Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia
|American Journal of Physiology-Renal Physiology|2013|308
Evidence-based clinical practice guidelines for cholelithiasis 2016
|Journal of Gastroenterology|2016|262